APA (7th ed.) Citation

Novotny-Diermayr, V., Sausgruber, N., Loh, Y. K., Pasha, M. K., Jayaraman, R., Hentze, H., . . . Wood, J. M. (2011). Pharmacodynamic Evaluation of the Target Efficacy of SB939, an Oral HDAC Inhibitor with Selectivity for Tumor Tissue. Molecular cancer therapeutics, 10(7), 1207-1217. https://doi.org/10.1158/1535-7163.MCT-11-0044

Chicago Style (17th ed.) Citation

Novotny-Diermayr, Veronica, et al. "Pharmacodynamic Evaluation of the Target Efficacy of SB939, an Oral HDAC Inhibitor with Selectivity for Tumor Tissue." Molecular Cancer Therapeutics 10, no. 7 (2011): 1207-1217. https://doi.org/10.1158/1535-7163.MCT-11-0044.

MLA (9th ed.) Citation

Novotny-Diermayr, Veronica, et al. "Pharmacodynamic Evaluation of the Target Efficacy of SB939, an Oral HDAC Inhibitor with Selectivity for Tumor Tissue." Molecular Cancer Therapeutics, vol. 10, no. 7, 2011, pp. 1207-1217, https://doi.org/10.1158/1535-7163.MCT-11-0044.